Inconsistent advice

Label warnings on the possible cardiovascular risk of ADHD medications are inconsistent and ambiguous, say experts  Product labelling warning of the cardiovascular risks of ADHD medication is inconsistent, say researchers who compared labelling across four countries, including Australia. Studying medication labelling, both for consumers and healthcare professionals, for five ADHD medications in Australia, Canada, the